KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $338 | +20.3% | 86,813 | +5.0% | 0.02% | 0.0% |
| Q4 2022 | $281 | -99.9% | 82,668 | -13.8% | 0.02% | -50.0% |
| Q3 2022 | $524,000 | -18.0% | 95,958 | -32.2% | 0.03% | -33.3% |
| Q2 2022 | $639,000 | +27.0% | 141,590 | +81.0% | 0.05% | -23.8% |
| Q4 2021 | $503,000 | -1.2% | 78,239 | -10.6% | 0.06% | -7.4% |
| Q3 2021 | $509,000 | +35.7% | 87,539 | +141.0% | 0.07% | -46.0% |
| Q2 2021 | $375,000 | – | 36,320 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |